Last updated on June 2018

Safety and Efficacy of Solithromycin in Adolescents and Children With Community-acquired Bacterial Pneumonia

Brief description of study

This is a phase 2/3, randomized, open-label, active control, multi-center study to assess the safety and efficacy of solithromycin in children and adolescents with community-acquired bacterial pneumonia (CABP).

Clinical Study Identifier: NCT02605122

Contact Investigators or Research Sites near you

Start Over

Robert Hernandez, PhD

Torokbalint, Hungary

Robert Hernandez, PhD

Budapest, Hungary